Literature DB >> 2586637

Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release.

C Allgaier1, T Jäger, G Hertting.   

Abstract

The effects of prostaglandin E2 (PGE2) on electrically evoked noradrenaline release in rat brain cortex were studied under conditions under which autoinhibition of release was avoided. When stimulation was carried out with 36 pulses at 3 Hz, 1 mumol/l PGE2, produced about 50% inhibition of release. In the presence of the alpha 2-adrenoceptor antagonist yohimbine (1 mumol/l) the effect of PGE2 was markedly increased. When release was elicited by 3 pulses/100 Hz the period of stimulation was too short to permit development of autoinhibition by released noradrenaline. Then the concentration-response-curve for PGE2 was very similar to that obtained under the above conditions (36 pulses/3 Hz, in the presence of yohimbine). These data suggest that both the alpha 2-adrenoceptor and the PGE2-receptor are linked to a common pathway. Since indometacin (10 mumol/l) did not enhance evoked transmitter release, an influence of endogenous PG's on in vitro release of noradrenaline from rat brain cortex slices can be excluded.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2586637     DOI: 10.1007/bf00167051

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  Letter: Interaction between indomethacin, oxymetazoline and phentolamine on the release of (3H)noradrenaline from brain slices.

Authors:  K Starke; H Montel
Journal:  J Pharm Pharmacol       Date:  1973-09       Impact factor: 3.765

2.  Effect of prostaglandin E 2 on central and peripheral catecholamine neurons.

Authors:  S Bergström; L O Farnebo; K Fuxe
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

3.  The endogenous biosynthesis of prostaglandins by brain tissue in vitro.

Authors:  L S Wolfe; K Rostworowski; H M Pappius
Journal:  Can J Biochem       Date:  1976-07

4.  The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade.

Authors:  C Allgaier; G Hertting; O V Kügelgen
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

5.  Presynaptic kappa-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the alpha 2-adrenoceptors.

Authors:  C Allgaier; B Daschmann; J Sieverling; G Hertting
Journal:  J Neurochem       Date:  1989-11       Impact factor: 5.372

6.  Effect of prostaglandins D2, E2 and F2alpha on catecholamine release from slices of rat and rabbit brain.

Authors:  W Reimann; H B Steinhauer; L Hedler; K Starke; G Hertting
Journal:  Eur J Pharmacol       Date:  1981-02-19       Impact factor: 4.432

7.  Influence of eicosanoids on serotonin release in the rat brain: inhibition by prostaglandins E1 and E2.

Authors:  E Schlicker; K Fink; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

8.  Regional distribution of arachidonic acid metabolites in rat brain following convulsive stimuli.

Authors:  E Berchtold-Kanz; H Anhut; R Heldt; B Neufang; G Hertting
Journal:  Prostaglandins       Date:  1981-07

9.  Presynaptic autoinhibition of central noradrenaline release in vitro: operational characteristics and effects of drugs acting at alpha-2 adrenoceptors in the presence of uptake inhibition.

Authors:  B Valenta; H Drobny; E A Singer
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

10.  Regulation of noradrenaline overflow in rat cerebral cortex by prostaglandin E2.

Authors:  K Hillier; W W Templeton
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

View more
  9 in total

1.  Estimation of the biophase concentration of noradrenaline at presynaptic alpha 2-adrenoceptors in brain slices.

Authors:  C Allgaier; E Agneter; T J Feuerstein; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

2.  Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.

Authors:  G Molderings; B Malinowska; E Schlicker
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

3.  Mutual interaction between presynaptic alpha 2-adrenoceptors and 5-HT1B receptors on the sympathetic nerve terminals of the rat inferior vena cava.

Authors:  G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

4.  Serotonin uptake blockers influence serotonin autoreceptors by increasing the biophase concentration of serotonin and not through a "molecular link".

Authors:  N Limberger; K Starke; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

5.  Involvement of presynaptic imidazoline receptors in the alpha 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives.

Authors:  M Göthert; G J Molderings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

6.  Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex.

Authors:  H J Exner; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

7.  Studies on the interaction between presynaptic alpha 2-adrenoceptors and adenosine A1 receptors located on noradrenergic nerve terminals.

Authors:  C Allgaier; R Greber; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

8.  Prejunctional opioid mu-receptors and adenosine A1-receptors on the sympathetic nerve endings of the rat tail artery interact with the alpha 2-adrenoceptors.

Authors:  B Bucher; C Corriu; J C Stoclet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

9.  Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.

Authors:  G J Molderings; E Colling; J Likungu; J Jakschik; M Göthert
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.